|
US4684620A
(en)
|
1984-09-04 |
1987-08-04 |
Gibson-Stephens Neuropharmaceuticals, Inc. |
Cyclic polypeptides having mu-receptor specificity
|
|
US4724229A
(en)
|
1986-09-30 |
1988-02-09 |
Smithkline Beckman Corporation |
Arg-arg-arg-vasopressin antagonists
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
CA2106314A1
(en)
|
1991-04-05 |
1992-10-06 |
John P. Burnier |
Platelet aggregation inhibitors having high specification for gpiibiiia
|
|
AU673731B2
(en)
|
1993-06-03 |
1996-11-21 |
Banyu Pharmaceutical Co., Ltd. |
Novel endothelin antagonistic peptide
|
|
US6037324A
(en)
|
1996-01-04 |
2000-03-14 |
Leukosite, Inc. |
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
US5990084A
(en)
|
1996-04-19 |
1999-11-23 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
GB9613112D0
(en)
|
1996-06-21 |
1996-08-28 |
Zeneca Ltd |
Chemical compounds
|
|
US7122623B2
(en)
*
|
1996-07-12 |
2006-10-17 |
Adherex Technologies, Inc. |
Compounds and methods for modulating cell adhesion
|
|
ATE356830T1
(de)
|
1996-08-30 |
2007-04-15 |
Novo Nordisk As |
Glp-1 derivate
|
|
US5942492A
(en)
|
1996-11-12 |
1999-08-24 |
Angstrom Pharmaceuticals, Inc. |
Cyclic peptides that bind to urokinase-type plasminogen activator receptor
|
|
WO1999002194A1
(en)
|
1997-07-11 |
1999-01-21 |
Innerdyne, Inc. |
Methods and systems for preparing and sealing radiation delivery structures
|
|
US6818617B1
(en)
|
1997-08-15 |
2004-11-16 |
Temple University- Of The Commonwealth System Of Higher Education |
EC-3, an inhibitor of α4β1 and α4β7 integrins
|
|
CA2309338A1
(en)
|
1997-11-24 |
1999-06-03 |
Merck & Co., Inc. |
Cyclic amino acid derivatives as cell adhesion inhibitors
|
|
EP1100473A2
(en)
|
1998-07-28 |
2001-05-23 |
InnerDyne, Inc. |
Absorbable brachytherapy and chemotherapy delivery devices and methods
|
|
JP2002522063A
(ja)
|
1998-08-17 |
2002-07-23 |
アブジェニックス インコーポレイテッド |
増加した血清半減期を有する改変された分子の生成
|
|
US6087334A
(en)
|
1998-08-21 |
2000-07-11 |
Amylin Pharmaceuticals, Inc. |
Anti-diabetic peptides
|
|
AUPP616498A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Synthesis of cyclic peptides
|
|
AUPP616598A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Auxiliary for amide bond formation
|
|
AUPP660698A0
(en)
|
1998-10-21 |
1998-11-12 |
University Of Queensland, The |
A method of protein engineering
|
|
US6451987B1
(en)
|
1999-03-15 |
2002-09-17 |
Novo Nordisk A/S |
Ion exchange chromatography of proteins and peptides
|
|
CN1344248A
(zh)
|
1999-03-17 |
2002-04-10 |
诺沃挪第克公司 |
肽的酰化方法和新酰化剂
|
|
KR20010110750A
(ko)
|
1999-04-12 |
2001-12-13 |
앤드류 앵뉴 |
인테그린 길항제로서의 치환된 비사이클릭 헤테로아릴화합물
|
|
WO2001068586A2
(en)
|
2000-03-14 |
2001-09-20 |
Novartis Ag |
α4β1 AND α4β7 INTEGRIN INHIBITORS
|
|
HUP0302544A3
(en)
|
2001-01-09 |
2012-09-28 |
Merck Patent Gmbh |
Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
|
|
DE10107707A1
(de)
|
2001-02-19 |
2002-08-29 |
Wilex Biotechnology Gmbh |
Antagonisten für alpha¶4¶beta¶7¶-Integrin
|
|
AUPS039702A0
(en)
|
2002-02-08 |
2002-03-07 |
University Of Queensland, The |
Common protein surface shapes and uses therefor
|
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
|
US7528223B2
(en)
|
2002-07-24 |
2009-05-05 |
Intercell Ag |
Antigens encoded by alternative reading frames from pathogenic viruses
|
|
WO2004058307A1
(en)
|
2002-12-18 |
2004-07-15 |
Wyeth |
Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof
|
|
US20070032417A1
(en)
|
2002-12-24 |
2007-02-08 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
EP1618131A2
(en)
|
2003-04-15 |
2006-01-25 |
Xenon Pharmaceuticals Inc. |
Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
|
|
PL2332968T3
(pl)
|
2003-11-05 |
2017-08-31 |
Dana-Farber Cancer Institute, Inc. |
Stabilizowane alfa-helikalne peptydy i ich zastosowania
|
|
EP1695255B1
(en)
|
2003-12-19 |
2016-09-07 |
Applied Biosystems, LLC |
Methods and systems for protein and peptide evidence assembly
|
|
JP4315982B2
(ja)
|
2004-01-09 |
2009-08-19 |
ファイザー インコーポレイティッド |
ＭＡｄＣＡＭに対する抗体
|
|
US8536140B2
(en)
|
2004-03-12 |
2013-09-17 |
Mti Meta Tech Inc. |
Methods for treating inflammatory bowel disease
|
|
JP2008504239A
(ja)
|
2004-06-24 |
2008-02-14 |
ザ ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ |
複合体およびその治療的使用
|
|
CA2581319A1
(en)
|
2004-09-23 |
2006-03-30 |
The University Of Melbourne |
Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
|
|
WO2006062685A2
(en)
|
2004-11-11 |
2006-06-15 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
|
WO2006058539A2
(en)
|
2004-11-30 |
2006-06-08 |
Gastrotech Pharma A/S |
Growth hormone secretagogue receptor 1a ligands
|
|
US20100183617A1
(en)
|
2005-02-23 |
2010-07-22 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating sas1r
|
|
US7534764B2
(en)
|
2005-06-29 |
2009-05-19 |
The Regents Of The University Of California |
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
|
|
US8076306B2
(en)
|
2006-04-12 |
2011-12-13 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to hepcidin
|
|
GB0610395D0
(en)
|
2006-05-25 |
2006-07-05 |
Ge Healthcare Ltd |
Novel imaging agents
|
|
CA2655372A1
(en)
|
2006-06-13 |
2007-12-21 |
Zymogenetics, Inc. |
Il-17 and il-23 antagonists and methods of using the same
|
|
US20080019913A1
(en)
|
2006-07-07 |
2008-01-24 |
University Of Arizona Office Of Technology Transfer |
Enkepahlin analogs with improved bioavailability
|
|
WO2008045252A2
(en)
*
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
|
US7713937B2
(en)
|
2006-11-10 |
2010-05-11 |
Cara Therapeutics, Inc. |
Synthetic peptide amides and dimeric forms thereof
|
|
US9193790B2
(en)
|
2006-12-07 |
2015-11-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of antagonists of the interaction between HIV GP120 and A4B7 integrin
|
|
CA2676036A1
(en)
|
2007-02-02 |
2008-08-14 |
Amgen Inc. |
Hepcidin, hepcidin antagonists and methods of use
|
|
HRP20120611T1
(hr)
|
2007-02-23 |
2012-10-31 |
Schering Corporation |
Anti-il-23p19 antitijela proizvedena genetiäśkim inžinjerstvom
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
CA2683145C
(en)
|
2007-04-27 |
2018-06-12 |
Katherine E. Lewis |
Antagonists to il-17a, il-17f, and il-23p19 and methods of use
|
|
US8313950B2
(en)
|
2007-05-21 |
2012-11-20 |
The Ohio State University Research Foundation |
Hepcidins as biomarkers for impending lupus nephritis flare
|
|
WO2009002947A2
(en)
|
2007-06-22 |
2008-12-31 |
Affymax, Inc. |
Compounds and peptides that bind the trail receptor
|
|
JP2011501941A
(ja)
|
2007-07-06 |
2011-01-20 |
バロリゼイション エイチエスジェイ， ソシエテ アン コマンディテ |
Ｉｌ−２３レセプターのアンタゴニストおよびその使用
|
|
CN101358201A
(zh)
|
2007-07-31 |
2009-02-04 |
钱忠明 |
重组人铁调素腺病毒、其制备方法及应用
|
|
CN101307085B
(zh)
|
2007-08-01 |
2012-06-13 |
香港理工大学深圳研究院 |
抑制铁调素调节蛋白的siRNA、重组慢病毒及其应用
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
GR1006896B
(el)
|
2007-08-24 |
2010-07-20 |
Ελληνικο Ινστιτουτο Παστερ, |
Μεθοδος παραγωγης μιας πεπτιδικης ορμονης
|
|
WO2009039185A1
(en)
|
2007-09-17 |
2009-03-26 |
The Trustees Of Columbia University In The City Of New York |
Uses of immunologically modified scaffold for tissue prevascularization and cell transplantation
|
|
WO2009045536A2
(en)
|
2007-10-05 |
2009-04-09 |
The University Of North Carolina At Chapel Hill |
Receptor targeted oligonucleotides
|
|
EP2373679B1
(en)
|
2008-12-05 |
2017-03-08 |
The Regents of The University of California |
Mini-hepcidin peptides and methods of using thereof
|
|
DE102009007381A1
(de)
|
2009-01-29 |
2010-08-05 |
Amp-Therapeutics Gmbh & Co. Kg |
Antibiotische Peptide
|
|
US8999935B2
(en)
|
2009-02-11 |
2015-04-07 |
New York University |
Treatment of osteoporosis in peri- and post-menopausal women with hepcidin
|
|
CN102459311B
(zh)
|
2009-04-08 |
2015-08-19 |
武田药品工业株式会社 |
神经调节肽u衍生物
|
|
TWI578992B
(zh)
|
2009-04-30 |
2017-04-21 |
諾克森製藥股份有限公司 |
與鐵調節激素（ｈｅｐｃｉｄｉｎ）結合之核酸類
|
|
CN104725472A
(zh)
|
2010-01-25 |
2015-06-24 |
康奈尔大学 |
芳香族阳离子肽及其用途
|
|
US9523073B2
(en)
|
2010-03-31 |
2016-12-20 |
Medical Diagnostic Laboratories, Llc |
Elisa for a naturally-occurring soluble truncated form of IL-23 receptor
|
|
JP2011231085A
(ja)
|
2010-04-30 |
2011-11-17 |
Osaka Prefecture Univ |
環状ペプチド
|
|
WO2011149942A2
(en)
|
2010-05-24 |
2011-12-01 |
Children's Medical Center Corporation |
Compositions and methods for plasma peptide analysis
|
|
ES2763404T3
(es)
|
2010-08-11 |
2020-05-28 |
Ironwood Pharmaceuticals Inc |
Formulaciones estables de linaclotida
|
|
EP2444101A1
(en)
|
2010-10-21 |
2012-04-25 |
Universitätsklinikum Freiburg |
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
|
|
WO2012101599A2
(en)
|
2011-01-27 |
2012-08-02 |
Ramot At Tel-Aviv University Ltd. |
Glycogen synthase kinase-3 inhibitors
|
|
US9605027B2
(en)
|
2011-06-14 |
2017-03-28 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
CN103764159A
(zh)
|
2011-06-14 |
2014-04-30 |
康肽德生物医药技术有限公司 |
芳香族阳离子肽及其用途
|
|
US8946150B2
(en)
|
2011-06-14 |
2015-02-03 |
Medical Diagnostic Laboratories, LLC. |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
US9169292B2
(en)
|
2011-06-14 |
2015-10-27 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
JP6571333B2
(ja)
|
2011-12-09 |
2019-09-04 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
改変ミニヘプシジンペプチドおよびその使用方法
|
|
WO2013177432A1
(en)
|
2012-05-23 |
2013-11-28 |
The University Of Chicago |
Methods of treating obesity
|
|
US9273093B2
(en)
|
2012-10-11 |
2016-03-01 |
Protagonist Therapeutics, Inc. |
α4β7 peptide dimer antagonists
|
|
WO2014127316A2
(en)
|
2013-02-15 |
2014-08-21 |
Srx Cardio, Llc |
Proprotein convertase subtilisin/kexin type 9 (pcsk9) allosteric binding ligands to mudulate serum low density lipoprotein (ldl) levels
|
|
KR102236829B1
(ko)
|
2013-03-15 |
2021-04-07 |
프로타고니스트 테라퓨틱스, 인코포레이티드 |
헵시딘 유사체 및 이의 용도
|
|
US20140294902A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide antagonists
|
|
US20140294901A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide dimer antagonists
|
|
DK3013351T3
(da)
|
2013-06-24 |
2020-01-27 |
Canbas Co Ltd |
Peptider og peptidmimetika i kombinationanvendelser og behandlinger til cancerpatient-subpopulationer
|
|
US10293020B2
(en)
|
2013-06-27 |
2019-05-21 |
Stealth Biotherapeutics Corp. |
Peptide therapeutics and methods for using same
|
|
WO2015054500A2
(en)
|
2013-10-09 |
2015-04-16 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
|
|
WO2015112700A1
(en)
|
2014-01-22 |
2015-07-30 |
Wisconsin Alumni Research Foundation |
Alpha/beta-peptide mimics of z-domain peptides
|
|
AU2015243990A1
(en)
|
2014-04-07 |
2016-11-10 |
La Jolla Pharmaceutical Company |
Hepcidin mimetic peptides and uses thereof
|
|
KR102787208B1
(ko)
|
2014-05-16 |
2025-03-27 |
프로타고니스트 테라퓨틱스, 인코포레이티드 |
α4β7 인테그린 티오에테르 펩티드 길항제
|
|
WO2015183963A2
(en)
|
2014-05-28 |
2015-12-03 |
Stealth Peptides International, Inc. |
Therapeutic compositions including redox-active parabenzoquinones and uses thereof
|
|
KR20170043509A
(ko)
|
2014-06-27 |
2017-04-21 |
프로타고니스트 테라퓨틱스, 인코포레이티드 |
헵시딘 및 미니-헵시딘 유사체 및 그의 용도
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
SG11201700327WA
(en)
|
2014-07-17 |
2017-02-27 |
Protagonist Therapeutics Inc |
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
|
|
KR20170108936A
(ko)
|
2014-10-01 |
2017-09-27 |
프로타고니스트 테라퓨틱스, 인코포레이티드 |
신규한 α4β7 펩타이드 단량체 및 이량체 길항제
|
|
WO2016054445A1
(en)
*
|
2014-10-01 |
2016-04-07 |
Protagonist Therapeutics, Inc. |
Novel cyclic monomer and dimer peptides having integrin antagonist activity
|
|
CA2970962A1
(en)
|
2014-12-29 |
2016-07-07 |
The Regents Of The University Of California |
S-alkylated hepcidin peptides and methods of making and using thereof
|
|
US20160199437A1
(en)
|
2015-01-08 |
2016-07-14 |
D. Travis Wilson |
Therapeutic compositions including iron chelators and uses thereof
|
|
US20170369871A1
(en)
|
2015-01-12 |
2017-12-28 |
Synthorx, Inc. |
Incorporation of unnatural nucleotides and methods thereof
|
|
US20160228491A1
(en)
|
2015-02-09 |
2016-08-11 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including phenazine-3-one and phenothiazine-3-one derivatives and uses thereof
|
|
WO2016195663A1
(en)
|
2015-06-02 |
2016-12-08 |
Stealth Peptides International, Inc. |
Therapeutic compositions including bpm 31510, variants and analogues thereof, and uses thereof
|
|
WO2016200364A1
(en)
|
2015-06-08 |
2016-12-15 |
Stealth Peptides International, Inc. |
THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF
|
|
MX384213B
(es)
|
2015-07-15 |
2025-03-14 |
Protagonist Therapeutics Inc |
Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias.
|
|
US10787490B2
(en)
|
2015-07-15 |
2020-09-29 |
Protaganist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
CA3009834A1
(en)
|
2015-12-30 |
2017-07-06 |
Protagonist Therapeutics, Inc. |
Analogues of hepcidin mimetics with improved in vivo half lives
|
|
US10407468B2
(en)
|
2016-03-23 |
2019-09-10 |
Protagonist Therapeutics, Inc. |
Methods for synthesizing α4β7 peptide antagonists
|
|
WO2018022937A1
(en)
|
2016-07-27 |
2018-02-01 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
|
|
US20200064357A1
(en)
|
2016-11-09 |
2020-02-27 |
Protagonist Therapeutics, Inc. |
Methods for determining and monitoring gastrointestinal inflammation
|
|
JP2020505352A
(ja)
|
2017-01-18 |
2020-02-20 |
プロタゴニスト セラピューティクス， インコーポレイテッド |
インターロイキン−２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用
|
|
US10278957B2
(en)
|
2017-09-11 |
2019-05-07 |
Protagonist Therapeutics, Inc. |
Opioid agonist peptides and uses thereof
|
|
WO2019157268A1
(en)
|
2018-02-08 |
2019-08-15 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
WO2019246273A1
(en)
|
2018-06-20 |
2019-12-26 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a jak or other kinase inhibitor
|
|
EP3820883A4
(en)
|
2018-07-12 |
2022-04-20 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
TW202116793A
(zh)
|
2019-07-10 |
2021-05-01 |
美商領導醫療有限公司 |
介白素-23受體之肽抑制劑及其於治療發炎疾病的用途
|